Exploiting novel models of endocrine-resistant breast cancer to identify new therapeutic targets

被引：1
|
作者：
Soosainathan, Arany
Nikitorowicz-Buniak, Joanna
Pancholi, Sunil
Iravani, Marjan
Alexander, John
Haider, Syed
Johnston, Stephen R.
Dowsett, Mitchell
Martin, Lesley A.
Isacke, Clare M.
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-P4-02-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-02-05
引用
收藏
页数：4
相关论文
共 50 条
  • [21] mTOR inhibitors: changing landscape of endocrine-resistant breast cancer
    Chumsri, Saranya
    Sabnis, Gauri
    Tkaczuk, Katherine
    Brodie, Angela
    FUTURE ONCOLOGY, 2014, 10 (03) : 443 - 456
  • [22] FASN inhibition as a potential treatment for endocrine-resistant breast cancer
    Gruslova, Aleksandra
    McClellan, Bryan
    Balinda, Henriette U.
    Viswanadhapalli, Suryavathi
    Alers, Victoria
    Sareddy, Gangadhara R.
    Huang, Tim
    Garcia, Michael
    deGraffenried, Linda
    Vadlamudi, Ratna K.
    Brenner, Andrew J.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (02) : 375 - 386
  • [23] Activation of AR inhibits growth of endocrine-resistant breast cancer
    Chia, K. M.
    Milioli, H.
    Portman, N.
    Laven-Law, G.
    Yong, A.
    Swarbrick, A.
    Caldon, L.
    Tilley, W.
    Hickey, T.
    Lim, E.
    CANCER RESEARCH, 2019, 79 (04)
  • [24] Novel selective estrogen receptors degraders regress tumors in pre-clinical models of endocrine-resistant breast cancer
    Hager, J. H.
    Darimont, B.
    Joseph, J.
    Govek, S.
    Grillot, K.
    Aparicio, A.
    Bischoff, E.
    Kahraman, M.
    Kaufman, J.
    Lai, A.
    Lee, K-J
    Lu, N.
    Nagasawa, J.
    Prudente, R.
    Qian, J.
    Sensintaffar, J.
    Shao, G.
    Heyman, R.
    Rix, P.
    Smith, N. D.
    CANCER RESEARCH, 2012, 72
  • [25] Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer
    Yubo Wang
    Jian Min
    Xiangping Deng
    Tian Feng
    Hebing Hu
    Xinyi Guo
    Yan Cheng
    Baohua Xie
    Yu Yang
    Chun-Chi Chen
    Rey-Ting Guo
    Chune Dong
    Hai-Bing Zhou
    Acta Pharmaceutica Sinica B, 2023, (12) : 4963 - 4982
  • [26] Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer
    Wang, Yubo
    Min, Jian
    Deng, Xiangping
    Feng, Tian
    Hu, Hebing
    Guo, Xinyi
    Cheng, Yan
    Xie, Baohua
    Yang, Yu
    Chen, Chun-Chi
    Guo, Rey-Ting
    Dong, Chune
    Zhou, Hai-Bing
    ACTA PHARMACEUTICA SINICA B, 2023, 13 (12) : 4963 - 4982
  • [27] A novel class of selective estrogen receptors degraders regresses tumors in pre-clinical models of endocrine-resistant breast cancer
    Joseph, James D.
    Darimont, Beatrice
    Govek, Steven
    Brigham, Dan
    Qian, Jing
    Sensintaffar, John
    Shao, Gang
    Aparicio, Anna
    Kahraman, Mehmet
    Lai, Andiliy
    Lee, Kyoung-Jin
    Lu, Nhin
    Nagasawa, Johnny
    Moon, Michael
    Rix, Peter
    Smith, Nick
    Hager, Jeff
    CANCER RESEARCH, 2014, 74 (19)
  • [28] A novel class of selective estrogen receptors degraders regresses tumors in pre-clinical models of endocrine-resistant breast cancer
    Darimont, Beatrice
    Govek, Steven
    Lu, Nihn
    Nagasawa, Johnny
    Prudente, Rene
    Qian, Jing
    Sensintaffar, John
    Shao, Gang
    Heyman, Richard
    Rix, Peter
    Smith, Nicholas
    Hager, Jeffrey
    Joseph, James
    Grillot, Katherine
    Aparicio, Anna
    Bischoff, Eric
    Kahraman, Mehmet
    Kaufman, Josh
    Lai, Andiliy
    Lee, Kyoung-Jin
    CLINICAL CANCER RESEARCH, 2012, 18 (10)
  • [29] Endocrine-resistant breast cancer: Underlying mechanisms and strategies for overcoming resistance
    Junichi Kurebayashi
    Breast Cancer, 2003, 10 (2) : 112 - 119
  • [30] PIK3CA mutations in endocrine-resistant breast cancer
    Schagerholm, Caroline
    Robertson, Stephanie
    Toosi, Hosein
    Sifakis, Emmanouil G.
    Hartman, Johan
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345